Results 201 to 210 of about 16,224 (212)

Methysergide in progressive supranuclear palsy

Neurology, 1985
A S, Duncombe, A J, Lees
openaire   +2 more sources

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease

Brain, 2012
Andrew John Lees, Peter Brown, Helen Ling   +2 more
exaly  

Pharmacological Therapy in Progressive Supranuclear Palsy

Archives of Neurology, 1998
Christopher Goetz, I Litvan, M Verny
exaly  

[18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy

Movement Disorders, 2017
Jennifer Whitwell, Clifford R Jack, M L Senjem   +2 more
exaly  

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome

Brain, 2007
Andrew John Lees, Janice Holton, Rohan de Silva   +2 more
exaly  

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

Lancet, The, 1999
Yoav Ben-Shlomo, Anette Schrag, N P Quinn   +2 more
exaly  

18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy

Brain, 2017
James Rowe, John T O'Brien, T E Cope
exaly  

Four-Repeat Tau Seeding in the Skin of Patients With Progressive Supranuclear Palsy

JAMA Neurology
Ivan Martinez-Valbuena, Anthony Lang, Gabor G Kovacs   +2 more
exaly  

An Autopsy Case of Progressive Supranuclear Palsy With Incidental ATXN2 Expansion

JAMA Neurology, 2018
Sung-Hye Park, Ahro Kim, Beomseok Jeon   +2 more
exaly  

Progressive supranuclear palsy presenting with primary progressive aphasia—Clinicopathological report of an autopsy case

Acta Neuropathologica, 2003
Ueda Y, Arai T, Tsuchiya K
exaly